DOCSLIB.ORG

Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Mo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Mo Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Somogyi, Aleksandra, Anton Petcherski, Benedikt Beckert, Mylene Huebecker, David A. Priestman, Antje Banning, Susan L. Cotman, Frances M. Platt, Mika O. Ruonala, and Ritva Tikkanen. 2018. “Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.” International Journal of Molecular Sciences 19 (2): 625. doi:10.3390/ ijms19020625. http://dx.doi.org/10.3390/ijms19020625. Published Version doi:10.3390/ijms19020625 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:35981875 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA International Journal of Molecular Sciences Article Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis Aleksandra Somogyi 1,†,‡, Anton Petcherski 1,†,§, Benedikt Beckert 2, Mylene Huebecker 3, David A. Priestman 3, Antje Banning 2, Susan L. Cotman 4, Frances M. Platt 3, Mika O. Ruonala 1,*,|| and Ritva Tikkanen 2,* ID 1 Center for Membrane Proteomics, Goethe University of Frankfurt, 60438 Frankfurt am Main, Germany; [email protected] (A.S.); [email protected] (A.P.) 2 Institute of Biochemistry, Medical Faculty, University of Giessen, Friedrichstrasse 24, 35292 Giessen, Germany; [email protected] (B.B.); [email protected] (A.B.) 3 Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK; [email protected] (M.H.); [email protected] (D.A.P.); [email protected] (F.M.P.) 4 Center for Genomic Medicine, Department of Neurology, Massachusetts General Hospital Research Institute, Harvard Medical School, 185 Cambridge Street, Boston, MA 02114, USA; [email protected] * Correspondence: [email protected] (M.O.R.); [email protected] (R.T.); Tel.: +49-641-9947 420 (R.T.) † These authors contributed equally to this work. ‡ Present Address: School of Biochemistry and Cell Biology, BioSciences Insitute, University College Cork, Cork T12YT20, Ireland. § Present Address: Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 650 Charles E Young Drive S, Los Angeles, CA 90095, USA. k Present Address: Image Computing & Information Technologies, Kapersburgstrasse 12, 60437 Frankfurt, Germany. Received: 1 February 2018; Accepted: 19 February 2018; Published: 22 February 2018 Abstract: Juvenile neuronal ceroid lipofuscinosis (JNCL) is caused by mutations in the CLN3 gene. Most JNCL patients exhibit a 1.02 kb genomic deletion removing exons 7 and 8 of this gene, which results in a truncated CLN3 protein carrying an aberrant C-terminus. A genetically accurate mouse model (Cln3Dex7/8 mice) for this deletion has been generated. Using cerebellar precursor cell lines generated from wildtype and Cln3Dex7/8 mice, we have here analyzed the consequences of the CLN3 deletion on levels of cellular gangliosides, particularly GM3, GM2, GM1a and GD1a. The levels of GM1a and GD1a were found to be significantly reduced by both biochemical and cytochemical methods. However, quantitative high-performance liquid chromatography analysis revealed a highly significant increase in GM3, suggesting a metabolic blockade in the conversion of GM3 to more complex gangliosides. Quantitative real-time PCR analysis revealed a significant reduction in the transcripts of the interconverting enzymes, especially of β-1,4-N-acetyl-galactosaminyl transferase 1 (GM2 synthase), which is the enzyme converting GM3 to GM2. Thus, our data suggest that the complex a-series gangliosides are reduced in Cln3Dex7/8 mouse cerebellar precursor cells due to impaired transcription of the genes responsible for their synthesis. Keywords: Batten disease; neuronal ceroid lipofuscinosis; CLN3; lysosomal storage disorders; glycosphingolipids; gangliosides Int. J. Mol. Sci. 2018, 19, 625; doi:10.3390/ijms19020625 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2018, 19, 625 2 of 18 1. Introduction Int. J. Mol. Sci. 2018, 19, x 2 of 17 Juvenile neuronal ceroid lipofuscinosis (JNCL) is a lysosomal storage disorder caused by mutations1. Introduction in the CLN3 gene. Most JNCL patients worldwide are homo- or heterozygous for a deletion that removesJuvenile exons neuronal 7 and 8ceroid together lipofuscinosis with thebridging (JNCL) is intron. a lysosomal A genetically storage authenticdisorder caused mouse by model for thismutations mutation in the has CLN3 been gene. generated, Most JNCL and patients it has worldwide been shown are to homo- recapitulate or heterozygous many of for the a deletion pathogenic featuresthat ofremoves human exons JNCL 7 and disease 8 together [1–6]. with One the of bridging the first intron. symptoms A genetically in JNCL authentic patients mouse is visual model system impairmentfor this mutation that frequently has been manifests generated, atand the it has age been of 5—8 shown years to recapitulate and leads tomany blindness of the pathogenic due to retinal degeneration.features of Withinhuman JNCL the first disease decade [1–6]. of One life, of the the patients’ first symptoms mental in and JNCL physical patients capabilities is visual system continue impairment that frequently manifests at the age of 5—8 years and leads to blindness due to retinal to decline, and epileptic seizures become evident. In addition to the central nervous system, JNCL degeneration. Within the first decade of life, the patients’ mental and physical capabilities continue patientsto decline, also exhibit and epileptic pathologic seizures features become in theevident. cardiac In addition and immune to the central systems. nervous Towards system, the JNCL end of the secondpatients decade also of exhibit life, many pathologic patients features rapidly in the deteriorate cardiac and and immune become systems. wheelchair Towards bound, the end with of the death usuallysecond occurring decade byof life, the agemany of patients 25. rapidly deteriorate and become wheelchair bound, with death Theusually gene occurring product, by the CLN3 age of protein, 25. is a transmembrane protein that is predicted to span the membraneThe 6 times,gene product, with both CLN3 N- protein, and C-terminus is a transmembrane residing inprotein the cytosol that is [predicted7,8]. Although to span the the exact molecularmembrane function 6 times, of the with CLN3 both protein N- and has C-terminus not been re conclusivelysiding in the verified, cytosol [7,8]. it has Although been linked the toexact various cellularmolecular processes function such of as the autophagy, CLN3 protein lysosomal has not pH, been vesicular conclusively trafficking verified, and it has cation been homeostasis linked to in various cellular processes such as autophagy, lysosomal pH, vesicular trafficking and cation lysosomes [2,4,9,10]. Furthermore, the CLN3 protein has been shown to be associated with cell homeostasis in lysosomes [2,4,9,10]. Furthermore, the CLN3 protein has been shown to be associated proliferation, control of cell cycle and apoptosis. However, it is not clear if these phenotypic features with cell proliferation, control of cell cycle and apoptosis. However, it is not clear if these phenotypic are directlyfeatures caused are directly by an caused impairment by an of impairment CLN3 protein of CLN3 function protein or if function they represent or if they secondary represent effects. Glycosphingolipidssecondary effects. (GSLs) are important glycan structures mainly residing at the cell surface, especiallyGlycosphingolipids in neuronal cells. (GSLs) GSLs are comprise important ceramide glycan structures linked to mainly a varying residing number at the of cell sugar surface, residues. Gangliosidesespecially arein neuronal a subgroup cells. ofGSLs GSLs, comprise distinguished ceramide linked by the to presence a varying of number sialic acidof sugar residues, residues. mainly N-acetylneuraminicGangliosides are a acid subgroup in humans of GSLs, [11 distinguished,12]. The biosynthesis by the presence pathway of sialic and acid the residues, structures mainly of the a-seriesN-acetylneuraminic gangliosides with acid their in humans synthesizing [11,12]. enzymesThe biosynthesis are shown pathway in Figure and the1, andstructures the genes of the and a- the respectiveseries enzymesgangliosides are with summarized their synthesizing in Table1 enzyme. GM3 iss are synthesized shown in Figure from lactosylceramide 1, and the genes and (LacCer) the by respective enzymes are summarized in Table 1. GM3 is synthesized from lactosylceramide (LacCer) the enzyme LacCer sialyltransferase (GM3 synthase) and is the precursor for the a-series gangliosides. by the enzyme LacCer sialyltransferase (GM3 synthase) and is the precursor for the a-series Conversion to GM2 takes place by the action of GM2 synthase (GalNAc transferase). Addition of gangliosides. Conversion
Load more

Recommended publications
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Palmitoyl-Protein Thioesterase 1 Deficiency in Drosophila Melanogaster Causes Accumulation
    Genetics: Published Articles Ahead of Print, published on February 1, 2006 as 10.1534/genetics.105.053306 Palmitoyl-protein thioesterase 1 deficiency in Drosophila melanogaster causes accumulation of abnormal storage material and reduced lifespan Anthony J. Hickey*,†,1, Heather L. Chotkowski*, Navjot Singh*, Jeffrey G. Ault*, Christopher A. Korey‡,2, Marcy E. MacDonald‡, and Robert L. Glaser*,†,3 * Wadsworth Center, New York State Department of Health, Albany, NY 12201-2002 † Department of Biomedical Sciences, State University of New York, Albany, NY 12201-0509 ‡ Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114 1 current address: Albany Medical College, Albany, NY 12208 2 current address: Department of Biology, College of Charleston, Charleston, SC 294243 3 corresponding author: Wadsworth Center, NYS Dept. Health, P. O. Box 22002, Albany, NY 12201-2002 E-mail: [email protected] 1 running title: Phenotypes of Ppt1-deficient Drosophila key words: Batten disease infantile neuronal ceroid lipofuscinosis palmitoyl-protein thioesterase CLN1 Drosophila corresponding author: Robert L. Glaser Wadsworth Center, NYS Dept. Health P. O. Box 22002 Albany, NY 12201-2002 E-mail: [email protected] phone: 518-473-4201 fax: 518-474-3181 2 ABSTRACT Human neuronal ceroid lipofuscinoses (NCLs) are a group of genetic neurodegenerative diseases characterized by progressive death of neurons in the central nervous system (CNS) and accumulation of abnormal lysosomal storage material. Infantile NCL (INCL), the most severe form of NCL, is caused by mutations in the Ppt1 gene, which encodes the lysosomal enzyme palmitoyl-protein thioesterase 1 (Ppt1). We generated mutations in the Ppt1 ortholog of Drosophila melanogaster in order to characterize phenotypes caused by Ppt1-deficiency in flies.
    [Show full text]
  • 743914V1.Full.Pdf
    bioRxiv preprint doi: https://doi.org/10.1101/743914; this version posted August 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis 2 and ER-associated degradation 3 4 Yicheng Wang1,2, Yusuke Maeda1, Yishi Liu3, Yoko Takada2, Akinori Ninomiya1, Tetsuya 5 Hirata1,2,4, Morihisa Fujita3, Yoshiko Murakami1,2, Taroh Kinoshita1,2,* 6 7 1Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan 8 2WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, 9 Japan 10 3Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, 11 School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, China 12 4Current address: Center for Highly Advanced Integration of Nano and Life Sciences (G- 13 CHAIN), Gifu University, 1-1 Yanagido, Gifu-City, Gifu 501-1193, Japan 14 15 *Correspondence and requests for materials should be addressed to T.K. (email: 16 [email protected]) 17 18 19 Glycosylphosphatidylinositol (GPI)-anchored proteins and glycosphingolipids interact with 20 each other in the mammalian plasma membranes, forming dynamic microdomains. How their 21 interaction starts in the cells has been unclear. Here, based on a genome-wide CRISPR-Cas9 22 genetic screen for genes required for GPI side-chain modification by galactose in the Golgi 23 apparatus, we report that b1,3-galactosyltransferase 4 (B3GALT4), also called GM1 24 ganglioside synthase, additionally functions in transferring galactose to the N- 25 acetylgalactosamine side-chain of GPI.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Dysregulation of Autophagy As a Common Mechanism in Lysosomal
    University of Birmingham Dysregulation of autophagy as a common mechanism in lysosomal storage diseases Seranova, Elena; Connolly, Kyle J; Zatyka, Malgorzata; Rosenstock, Tatiana R; Barrett, Timothy; Tuxworth, Richard I; Sarkar, Sovan DOI: 10.1042/EBC20170055 10.1042/EBC20170055 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Seranova, E, Connolly, KJ, Zatyka, M, Rosenstock, TR, Barrett, T, Tuxworth, RI & Sarkar, S 2017, 'Dysregulation of autophagy as a common mechanism in lysosomal storage diseases', Essays in Biochemistry, vol. 61, no. 6, pp. 733-749. https://doi.org/10.1042/EBC20170055, https://doi.org/10.1042/EBC20170055 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked for eligibility: 08/01/2018 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • ©Ferrata Storti Foundation
    Original Articles T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response Peter Van Loo,1,2,3 Thomas Tousseyn,4 Vera Vanhentenrijk,4 Daan Dierickx,5 Agnieszka Malecka,6 Isabelle Vanden Bempt,4 Gregor Verhoef,5 Jan Delabie,6 Peter Marynen,1,2 Patrick Matthys,7 and Chris De Wolf-Peeters4 1Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium; 2Department of Human Genetics, K.U.Leuven, Leuven, Belgium; 3Bioinformatics Group, Department of Electrical Engineering, K.U.Leuven, Leuven, Belgium; 4Department of Pathology, University Hospitals K.U.Leuven, Leuven, Belgium; 5Department of Hematology, University Hospitals K.U.Leuven, Leuven, Belgium; 6Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway, and 7Department of Microbiology and Immunology, Rega Institute for Medical Research, K.U.Leuven, Leuven, Belgium Citation: Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, and De Wolf-Peeters C. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolero- genic host immune response. Haematologica. 2010;95:440-448. doi:10.3324/haematol.2009.009647 The Online Supplementary Tables S1-5 are in separate PDF files Supplementary Design and Methods One microgram of total RNA was reverse transcribed using random primers and SuperScript II (Invitrogen, Merelbeke, Validation of microarray results by real-time quantitative Belgium), as recommended by the manufacturer. Relative reverse transcriptase polymerase chain reaction quantification was subsequently performed using the compar- Ten genes measured by microarray gene expression profil- ative CT method (see User Bulletin #2: Relative Quantitation ing were validated by real-time quantitative reverse transcrip- of Gene Expression, Applied Biosystems).
    [Show full text]
  • ROS and Hypoxia Signaling Regulate Periodic Metabolic Arousal During Insect Dormancy to Coordinate Glucose, Amino Acid, and Lipid Metabolism
    ROS and hypoxia signaling regulate periodic metabolic arousal during insect dormancy to coordinate glucose, amino acid, and lipid metabolism Chao Chena,1, Rohit Maharb, Matthew E. Merrittb, David L. Denlingerc,d,1, and Daniel A. Hahna,e,1 aDepartment of Entomology and Nematology, The University of Florida, Gainesville, FL 32611-0620; bDepartment of Biochemistry and Molecular Biology, The University of Florida, Gainesville, FL 32610-0245; cDepartment of Entomology, 300 Aronoff Laboratory, The Ohio State University, Columbus, OH 43210; dDepartment of Evolution, Ecology, and Organismal Biology, The Ohio State University, 300 Aronoff Laboratory, Columbus, OH 43210; and eGenetics Institute, The University of Florida, Gainesville, FL 32610-3610 Contributed by David L. Denlinger, November 5, 2020 (sent for review August 20, 2020; reviewed by Kendra J. Greenlee and Vladimír Košál) Metabolic suppression is a hallmark of animal dormancy that dormant organisms maintain relatively constant lowered metabo- promotes overall energy savings. Some diapausing insects and lism, others including a few mammalian hibernators and a few some mammalian hibernators have regular cyclic patterns of diapausing insects regularly fluctuate between strong metabolic substantial metabolic depression alternating with periodic arousal depression and short bursts of higher metabolic activity, termed where metabolic rates increase dramatically. Previous studies, periodic arousal (5, 8). The flesh fly Sarcophaga crassipalpis Mac- largely in mammalian hibernators, have shown that periodic quart (Diptera: Sarcophagidae) shows dramatic metabolic sup- arousal is driven by an increase in aerobic mitochondrial metab- pression during their multiple-month pupal diapause with less than olism and that many molecules related to energy metabolism 10% of the CO2 output of nondiapausing pupae (9).
    [Show full text]
  • Cross-Talks of Glycosylphosphatidylinositol Biosynthesis with Glycosphingolipid Biosynthesis and ER-Associated Degradation
    ARTICLE https://doi.org/10.1038/s41467-020-14678-2 OPEN Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis and ER-associated degradation Yicheng Wang 1,2, Yusuke Maeda 1, Yi-Shi Liu3, Yoko Takada 2, Akinori Ninomiya 1, Tetsuya Hirata1,2,4, ✉ Morihisa Fujita3, Yoshiko Murakami 1,2 & Taroh Kinoshita 1,2 1234567890():,; Glycosylphosphatidylinositol (GPI)-anchored proteins and glycosphingolipids interact with each other in the mammalian plasma membranes, forming dynamic microdomains. How their interaction starts in the cells has been unclear. Here, based on a genome-wide CRISPR-Cas9 genetic screen for genes required for GPI side-chain modification by galactose in the Golgi apparatus, we report that β1,3-galactosyltransferase 4 (B3GALT4), the previously char- acterized GM1 ganglioside synthase, additionally functions in transferring galactose to the N- acetylgalactosamine side-chain of GPI. Furthermore, B3GALT4 requires lactosylceramide for the efficient GPI side-chain galactosylation. Thus, our work demonstrates previously unex- pected functional relationships between GPI-anchored proteins and glycosphingolipids in the Golgi. Through the same screening, we also show that GPI biosynthesis in the endoplasmic reticulum (ER) is severely suppressed by ER-associated degradation to prevent GPI accu- mulation when the transfer of synthesized GPI to proteins is defective. Our data demon- strates cross-talks of GPI biosynthesis with glycosphingolipid biosynthesis and the ER quality control system. 1 Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. 2 WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan. 3 Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, China.
    [Show full text]
  • Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses
    551 38 Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses Marie T. Vanier, Catherine Caillaud, Thierry Levade 38.1 Disorders of Sphingolipid Synthesis – 553 38.2 Sphingolipidoses – 556 38.3 Niemann-Pick Disease Type C – 566 38.4 Neuronal Ceroid Lipofuscinoses – 568 References – 571 J.-M. Saudubray et al. (Eds.), Inborn Metabolic Diseases, DOI 10.1007/978-3-662-49771-5_ 38 , © Springer-Verlag Berlin Heidelberg 2016 552 Chapter 38 · Disor ders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses O C 22:0 (Fatty acid) Ganglio- series a series b HN OH Sphingosine (Sphingoid base) OH βββ β βββ β Typical Ceramide (Cer) -Cer -Cer GD1a GT1b Glc ββββ βββ β Gal -Cer -Cer Globo-series GalNAc GM1a GD1b Neu5Ac βαββ -Cer Gb4 ββ β ββ β -Cer -Cer αβ β -Cer GM2 GD2 Sphingomyelin Pcholine-Cer Gb3 B4GALNT1 [SPG46] [SPG26] β β β ββ ββ CERS1-6 GBA2 -Cer -Cer ST3GAL5 -Cer -Cer So1P So Cer GM3 GD3 GlcCer - LacCer UDP-Glc UDP Gal CMP -Neu5Ac - UDP Gal PAPS Glycosphingolipids GalCer Sulfatide ββ Dihydro -Cer -Cer SO 4 Golgi Ceramide apparatus 2-OH- 2-OH-FA Acyl-CoA FA2H CERS1-6 [SPG35] CYP4F22 ω-OH- ω-OH- FA Acyl-CoA ULCFA ULCFA-CoA ULCFA GM1, GM2, GM3: monosialo- Sphinganine gangliosides Endoplasmic GD3, GD2, GD1a, GD1b: disialo-gangliosides reticulum KetoSphinganine GT1b: trisialoganglioside SPTLC1/2 [HSAN1] N-acetyl-neuraminic acid: sialic acid found in normal human cells Palmitoyl-CoA Deoxy-sphinganine + Serine +Ala or Gly Deoxymethylsphinganine 38 . Fig. 38.1 Schematic representation of the structure of the main sphingolipids , and their biosynthetic pathways.
    [Show full text]
  • Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells
    cells Review Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells Ewa Gurgul-Convey Institute of Clinical Biochemistry, Hannover Medical School, Carl-Neuberg-Str.1, 30625 Hannover, Germany; [email protected] Received: 30 June 2020; Accepted: 3 August 2020; Published: 4 August 2020 Abstract: Type 1 diabetes (T1DM) is a chronic autoimmune disease, with a strong genetic background, leading to a gradual loss of pancreatic beta-cells, which secrete insulin and control glucose homeostasis. Patients with T1DM require life-long substitution with insulin and are at high risk for development of severe secondary complications. The incidence of T1DM has been continuously growing in the last decades, indicating an important contribution of environmental factors. Accumulating data indicates that sphingolipids may be crucially involved in T1DM development. The serum lipidome of T1DM patients is characterized by significantly altered sphingolipid composition compared to nondiabetic, healthy probands. Recently, several polymorphisms in the genes encoding the enzymatic machinery for sphingolipid production have been identified in T1DM individuals. Evidence gained from studies in rodent islets and beta-cells exposed to cytokines indicates dysregulation of the sphingolipid biosynthetic pathway and impaired function of several sphingolipids. Moreover, a number of glycosphingolipids have been suggested to act as beta-cell autoantigens. Studies in animal models of autoimmune diabetes, such as the Non Obese Diabetic (NOD) mouse and the LEW.1AR1-iddm (IDDM) rat, indicate a crucial role of sphingolipids in immune cell trafficking, islet infiltration and diabetes development. In this review, the up-to-date status on the findings about sphingolipids in T1DM will be provided, the under-investigated research areas will be identified and perspectives for future studies will be given.
    [Show full text]